Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRuDENTE: Metformin for Diabetes Prevention in Mexico City
NCT03194009Unknown
- Sponsor
- Instituto Nacional de Salud Pública
- Start
- Aug 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Instituto Nacional de Salud Pública. Primary endpoint: Incidence of Type 2 Diabetes Mellitus at 3 years. Status: unknown.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03194009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03194009.